David M. Rodman

7.8k citations

100 papers · 5.6k indexed · 1 hit paper · h-index 40

Pulmonary and Respiratory Medicine top 0.5%
Physiology top 1%
Molecular Biology top 5%
Cardiology and Cardiovascular Medicine top 2%
Endocrine and Autonomic Systems top 1%

Co-authors: Ivan F. McMurtry Karen A. Fagan Brian Fouty Richard F. OʼBrien Steven H. Abman James West Richard H. Simon Bruce C. Marshall
Topics: Nitric Oxide and Endothelin Effects (38 papers)Pulmonary Hypertension Research and Treatments (30 papers)Neuroscience of respiration and sleep (14 papers)
Cited by: Endocrine and Autonomic Systems Pulmonary and Respiratory Medicine Physiology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Circulation
Partner nations: United States Germany France

In The Last Decade

David M. Rodman

99 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

2014 336 citations David Waltz, David M. Rodman et al. profile →

Peers

Countries citing papers authored by David M. Rodman

Since Specialization

Citations

This map shows the geographic impact of David M. Rodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Rodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Rodman more than expected).

Fields of papers citing papers by David M. Rodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Rodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Rodman. The network helps show where David M. Rodman may publish in the future.

Co-authorship network of co-authors of David M. Rodman

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Rodman. A scholar is included among the top collaborators of David M. Rodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Rodman. David M. Rodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lorundrostat, a Novel Aldosterone Synthase Inhibitor (ASI), in Participants with Uncontrolled Hypertension, CKD, and Albuminuria: Results from Explore-CKD 2025 ·Journal of the American Society of Nephrology ·Matthew R. Weir,(unknown),Keung Lee,(unknown),Laura Kooienga,Branko Kopjar,(unknown),David M. Rodman	0
2	Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene 2020 ·Investigative Ophthalmology & Visual Science ·Stephen R. Russell,Arlene V. Drack,Artur V. Cideciyan,Samuel G. Jacobson,Bart P. Leroy,Wanda Pfeifer,Alina V. Dumitrescu,(unknown),Allen C. Ho,Caroline Van Cauwenbergh,Julie De Zaeytijd,Aniz Girach,(unknown),(unknown),David M. Rodman	3
3	The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation 2013 ·Journal of Cystic Fibrosis ·(unknown),David M. Rodman,Fredrick Van Goor,Andreas Schmelz,Peter S. Mueller	17
4	The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge 2011 ·Journal of Allergy and Clinical Immunology ·Grant C. Nicholson,Harsha H. Kariyawasam,Andrew J. Tan,Jens M. Hohlfeld,Deborah A. Quinn,Christoph Walker,David M. Rodman,John Westwick,Stipo Jurčević,Onn Min Kon,Peter J. Barnes,Norbert Krug,Trevor T. Hansel	44
5	Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease 2008 ·American Journal of Respiratory and Critical Care Medicine ·Milene T. Saavedra,Grant Hughes,Linda Sanders,Michele M. Carr,David M. Rodman,Christopher D. Coldren,Mark W. Geraci,Scott D. Sagel,Frank J. Accurso,James West,Jerry A. Nick	15
6	Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle 2007 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Moira Hagen,Karen Fagan,Wolfgang Steudel,Michele M. Carr,Kirk B. Lane,David M. Rodman,James West	129
7	Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·David M. Rodman,(unknown),Sonya L. Heltshe,Marci K. Sontag,(unknown),(unknown),(unknown),Gwen A. Huitt,Michael D. Iseman,Milene T. Saavedra,Lynn M. Taussig,Jeffrey S. Wagener,Frank J. Accurso,Jerry A. Nick	119
8	Manifestations of cystic fibrosis diagnosed in adulthood 2005 ·Current Opinion in Internal Medicine ·Jerry A. Nick,David M. Rodman	28
9	Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Can Induce Apoptosis in Subsets of Premalignant Cells 2004 ·American Journal Of Pathology ·Xiaojun Lu,Jack L. Arbiser,James West,(unknown),Alison D. Sheridan,Baskaran Govindarajan,Julie W. Harral,David M. Rodman,Brian Fouty	14
10	Adenoviral gene transfer to the neonatal rat pulmonary circulation 2004 ·The Journal of Gene Medicine ·James West,(unknown),(unknown),Yuji Tada,Karen Fagan,David M. Rodman	1
11	Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia 2004 ·American Journal of Physiology-Heart and Circulatory Physiology ·Cynthia L. Hartsfield,Ivan F. McMurtry,D. Dunbar Ivy,Kenneth G. Morris,(unknown),David M. Rodman,Karen A. Fagan	17
12	Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis 2004 ·CHEST Journal ·Richard B. Moss,David M. Rodman,L. Terry Spencer,Moira L. Aitken,Pamela L. Zeitlin,David Waltz,Carlos Milla,Alan S. Brody,John P. Clancy,Bonnie W. Ramsey,N. Hamblett,Alison E. Heald	292
13	Chronic mucoid Pseudomonas aeruginosa cholangitis complicating ERCP in a CF patient 2002 ·Journal of Cystic Fibrosis ·(unknown),Matthew Dickinson,David S. James,Marcelo Kugelmas,Nancy Madinger,David M. Rodman	2
14	Tuberous sclerosis gene products in proliferation control 2001 ·Mutation Research/Reviews in Mutation Research ·Markus Hengstschläger,David M. Rodman,(unknown),Elke Hengstschläger-Ottnad,Margit Rosner,Mikael Kubista	46
15	Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension 2001 ·Respiratory Research ·Karen A. Fagan,Brian Morrissey,Brian Fouty,Koichi Sato,Julie W. Harral,Kenneth G. Morris,(unknown),(unknown),Ivan F. McMurtry,David M. Rodman	80
16	The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia 1999 ·Journal of Clinical Investigation ·Karen A. Fagan,Brian Fouty,Robert Claude Tyler,Kenneth G. Morris,(unknown),Koichi Sato,Timothy D. Le Cras,Steven H. Abman,Howard D. Weinberger,Paul L. Huang,Ivan F. McMurtry,David M. Rodman	253
17	Polycationic Lipid-Mediated Gene Transfer to the Abnormal Pulmonary Circulation 1997 ·CHEST Journal ·Robert Claude Tyler,Clayton Bullock,(unknown),Cori Gorman,(unknown),Rubin M. Tuder,Ivan F. McMurtry,David M. Rodman	3
18	Difference in Effect of Inhibitors of Energy Metabolism on Endothelium-dependent Relaxation of Rat Pulmonary Artery and Aorta 1991 ·American Journal of Respiratory Cell and Molecular Biology ·David M. Rodman,(unknown),Ivan F. McMurtry	14
19	Effects of K ⁺ Channel Blockers on Vascular Tone in the Perfused Rat Lung 1991 ·American Review of Respiratory Disease ·(unknown),David M. Rodman,(unknown)	90
20	Successful Treatment of Sarcoidosis-Associated Pulmonary Hypertension with Corticosteroids 1990 ·CHEST Journal ·David M. Rodman,JoAnn Lindenfeld	38

About David M. Rodman

David M. Rodman is a scholar working on Endocrine and Autonomic Systems, Biochemistry and Physiology, having authored 100 papers that have together received 5.6k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (38 papers), Pulmonary Hypertension Research and Treatments (30 papers) and Neuroscience of respiration and sleep (14 papers). The work is most often cited by research in Endocrine and Autonomic Systems (693 citations), Pulmonary and Respiratory Medicine (3.3k citations) and Physiology (2.1k citations). David M. Rodman has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Ivan F. McMurtry, Karen A. Fagan, Brian Fouty, Richard F. OʼBrien, Steven H. Abman, James West, Richard H. Simon, Bruce C. Marshall, Beth Sufian and James R. Yankaskas. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact